Completed
LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
NCT00525148
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1200.22.28 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
- 1200.22.32 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
- 1200.22.4 Boehringer Ingelheim Investigational Site Mission Hills, California, United States
- 1200.22.16 Boehringer Ingelheim Investigational Site Orange, California, United States